Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study

SIMPLE SUMMARY: The present study explored the predictors of the development of liver-related events in HCV cirrhotic subjects achieving SVR following antiviral therapy with direct-acting antiviral agents (DAAs) during a follow-up of 24 months after SVR confirmation. Patients had a liver stiffness m...

Descripción completa

Detalles Bibliográficos
Autores principales: Morisco, Filomena, Federico, Alessandro, Marignani, Massimo, Cannavò, Mariarita, Pontillo, Giuseppina, Guarino, Maria, Dallio, Marcello, Begini, Paola, Benigno, Rosa G., Lombardo, Flavia L., Stroffolini, Tommaso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345116/
https://www.ncbi.nlm.nih.gov/pubmed/34359711
http://dx.doi.org/10.3390/cancers13153810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345116/
https://www.ncbi.nlm.nih.gov/pubmed/34359711
http://dx.doi.org/10.3390/cancers13153810

Ejemplares similares